Gene · 699
Papers3,725
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
101 to 120 of 3,725
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Unveiling the molecular mechanisms of human platelet lysate in enhancing endometrial receptivity. | Hum Reprod | 2025 | 40663777 | PubTator, text mining | PubMed |
| Exploring the pathogenesis of extranodal natural killer/T cell lymphoma complicated With EBV via microarray data analysis. | Leuk Res | 2025 | 40591982 | PubTator, text mining | PubMed |
| Computational Structural Comparison of Toxoplasma gondii CDPK1 and Human BUB1 kinases: Implications for Selective Inhibitor Design. | ACS Omega | 2025 | 40584317 | PubTator, text mining | PubMed |
| Identification of potential biomarkers associated with immune cell infiltration patterns in Kawasaki disease via bioinformatics. | PLoS One | 2025 | 40455761 | PubTator, text mining | PubMed |
| Interplay of kinetochores and catalysts drives rapid assembly of the mitotic checkpoint complex. | Nat Commun | 2025 | 40410156 | PubTator, text mining | PubMed |
| Pan-cancer oncogenic properties and therapeutic potential of SF3B4. | Cancer Gene Ther | 2025 | 40394232 | PubTator, text mining | PubMed |
Identification of key biomarker genes in liver hepatocellular carcinoma and kidney renal clear cell carcinoma progression: A shared high-throughput screening and molecular docking method with potentials for targeted therapeutic interventions. | J Genet Eng Biotechnol | 2025 | 40390492 | PubTator, text mining | PubMed |
| FTO Promotes Hepatocellular Carcinoma Progression by Mediating m6A Modification of BUB1 and Targeting TGF-βR1 to Activate the TGF-β Signaling Pathway. | J Clin Transl Hepatol | 2025 | 40385944 | PubTator, text mining | PubMed |
| A bioinformatics exploration of lung adenocarcinoma identifies hub genes with prognostic significance: from data to discovery. | J Egypt Natl Canc Inst | 2025 | 40320470 | PubTator, text mining | PubMed |
| Transcriptomic signatures of prostate cancer progression: a comprehensive RNA-seq study. | 3 Biotech | 2025 | 40260408 | PubTator, text mining | PubMed |
| Non-invasive liquid biopsy based on transcriptomic profiling for early diagnosis of occult peritoneal metastases in locally advanced gastric cancer. | NPJ Precis Oncol | 2025 | 40234664 | PubTator, text mining | PubMed |
| BUB1, miR-495-3p, and E2F1/E2F8 axis is associated with poor prognosis of breast cancer patients and infiltration of Th2 cells in the tumor microenvironment. | Cancer Biomark | 2025 | 40183319 | PubTator, text mining | PubMed |
| Genome-wide CRISPR screen identifies BUB1 kinase as a druggable vulnerability in malignant pleural mesothelioma. | Cell Death Dis | 2025 | 40180891 | PubTator, text mining | PubMed |
| PBK as a novel biomarker performed excellent diagnostic and prognostic value in HCC associated with immune infiltration and methylation. | J Mol Histol | 2025 | 40178670 | PubTator, text mining | PubMed |
| Discovering potential therapeutic targets in glioblastoma multiforme using a multi-omics approach. | Pathol Res Pract | 2025 | 40168776 | PubTator, text mining | PubMed |
| A chemical-genetic system to rapidly inhibit the PP2A-B56 phosphatase reveals a role at metaphase kinetochores. | Nat Commun | 2025 | 40157924 | PubTator, text mining | PubMed |
| Comprehensive analysis of intervention and control studies for the computational identification of dengue biomarker genes. | PLoS Negl Trop Dis | 2025 | 40100920 | PubTator, text mining | PubMed |
| Identifcation of the FGF family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. | SLAS Technol | 2025 | 40086631 | PubTator, text mining | PubMed |
| BUB1-deficiency suppresses kidney renal clear cell carcinoma progression via the PI3K/Akt pathway: A bioinformatics-oriented validating study. | Mol Cell Probes | 2025 | 40081509 | PubTator, text mining | PubMed |
| Developing a gene expression classifier for breast cancer diagnosis. | Med Biol Eng Comput | 2025 | 40080330 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/699/papers?page=6